A double blind randomised controlled trial comparing standard dose of iron supplementation for pregnant women with two screen-and-treat approaches using hepcidin as a biomarker for ready and safe to receive iron

BMC Pregnancy and Childbirth

Volumn 16, Issue 1, 2016, Pages

  Bah, Amat ^a   Wegmuller, Rita ^a   Cerami, Carla ^a   Kendall, Lindsay ^a   Pasricha, Sant Rayn ^b   Moore, Sophie E ^c   Prentice, Andrew M ^a  

^a MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c MRC HUMAN NUTRITION RESEARCH   (United Kingdom)

Author keywords

Anaemia; Hepcidin; Iron deficiency; Lower dose iron; Pregnancy; UNIMMAP

Indexed keywords

BIOLOGICAL MARKER; HEMOGLOBIN; HEPCIDIN; IRON; PLACEBO; TRACE ELEMENT;

ADULT; ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; GAMBIA; HUMAN; INFECTION SENSITIVITY; IRON DEFICIENCY ANEMIA; IRON THERAPY; MAJOR CLINICAL STUDY; MASS SCREENING; MEDICATION COMPLIANCE; PATIENT COMPLIANCE; PREGNANT WOMAN; RANDOMIZED CONTROLLED TRIAL; RURAL AREA; ANEMIA, IRON-DEFICIENCY; BLOOD; DIETARY SUPPLEMENT; MATERNAL SERUM SCREENING TEST; PREGNANCY; PREGNANCY COMPLICATIONS; PROCEDURES; RANDOMIZED CONTROLLED TRIAL (TOPIC); TREATMENT OUTCOME; YOUNG ADULT;

ADULT; ANEMIA, IRON-DEFICIENCY; BIOMARKERS; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FEMALE; GAMBIA; HEPCIDINS; HUMANS; IRON; MATERNAL SERUM SCREENING TESTS; PREGNANCY; PREGNANCY COMPLICATIONS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TRACE ELEMENTS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84979658586     PISSN: None     EISSN: 14712393     Source Type: Journal    
DOI: 10.1186/s12884-016-0934-8     Document Type: Article

References (34)

1. WHO. Worldwide prevalence of anaemia 1993-2005. 2008.
2. Galloway R, Dusch E, Elder L, Achadi E, Grajeda R, Hurtado E, Favin M, Kanani S, Marsaban J, Meda N, Moore KM, Morison L, Raina N, Rajaratnam J, Rodriquez J and Stephen C. Women's perceptions of iron deficiency and anemia prevention and control in eight developing countries. Soc Sci Med. 2002;55(4):529-44.
3. WHO. The World Health Report: Reducing risks, promoting healthy life. 2002.
4. Bah A, Semega-Janneh I, Prentice AM, Bates C. Nationwide survey on the prevalence of vitamin A and iron deficiency in women and children in the Gambia. Banjul: National Nutrition Agency; 2001.
5. Kohgo Y, Torimoto Y, Kato J. Transferrin receptor in tissue and serum: updated clinical significance of soluble receptor. Int J Hematol. 2002;76(3):213-8.
6. Lynch S. Case studies: iron. Am J Clin Nutr. 2011;94(2):673S-8S.
7. de Mast Q, Syafruddin D, Keijmel S, Riekerink TO, Deky O, Asih PB, Swinkels DW, van der Ven AJ. Increased serum hepcidin and alterations in blood iron parameters associated with asymptomatic P. falciparum and P. vivax malaria. Haematologica. 2010;95(7):1068-74.
8. Ganz T. Hepcidin and iron regulation, 10 years later. Blood. 2011;117(17):4425-33.
9. Anderson GJ, Frazer DM, Wilkins SJ, Becker EM, Millard KN, Murphy TL, McKie AT, Vulpe CD. Relationship between intestinal iron-transporter expression, hepatic hepcidin levels and the control of iron absorption. Biochem Soc Trans. 2002;30:724-6.
10. Nicolas G, Chauvet C, Viatte L, Danan JL, Bigard X, Devaux I, Beaumont C, Kahn A and Vaulont S. The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. J Clin Invest. 2002;110:1037-44.
11. Huang H, Constante M, Layoun A, Santos MM. Contribution of STAT3 and SMAD4 pathways to the regulation of hepcidin by opposing stimuli. Blood. 2009;113:3593-9.
12. Pasricha SR, McQuilten Z, Westerman M, Keller A, Nemeth E, Ganz T, Wood E. Serum hepcidin as a diagnostic test of iron deficiency in premenopausal female blood donors. Haematologica. 2011;96(8):1099-105.
13. Kemna EH, Tjalsma H, Willems HL, Swinkels DW. Hepcidin: from discovery to differential diagnosis. Haematologica. 2008;93(1):90-7.
14. Heming N, Montravers P, Lasocki S. Iron deficiency in critically ill patients: highlighting the role of hepcidin. Crit Care. 2011;15(2):210.
15. Kroot JJ, Tjalsma H, Fleming RE, Swinkels DW. Hepcidin in human iron disorders: diagnostic implications. Clin Chem. 2011;57(12):1650-69.
16. Thomas C, Kobold U, Thomas L. Serum hepcidin-25 in comparison to biochemical markers and hematological indices for the differentiation of iron-restricted erythropoiesis. Clin Chem Lab Med. 2011;49(2):207-13.
17. Andrews NC, Schmidt PJ. Iron homeostasis. Annu Rev Physiol. 2007;69:69-85.
18. Ganz T, Nemeth E. Regulation of iron acquisition and iron distribution in mammals. Biochim Biophys Acta. 2006;1763(7):690-9.
19. Young B, Zaritsky J. Hepcidin for clinicians. Clin J Am Soc Nephrol. 2009;4(8):1384-7.
20. Prentice AM, Doherty CP, Abrams SA, Cox SE, Atkinson SH, Verhoef H, Armitage AE and Drakesmith H. Hepcidin is the major predictor of erythrocyte iron incorporation in anemic African children. Blood. 2012;119(8):1922-8.
21. WHO. Iron Deficiency Anaemia Assessment, Prevention, and Control. Guide for Programme Managers. 2001.
22. Senga EL, Harper G, Koshy G, Kazembe PN, Brabin BJ. Reduced risk for placental malaria in iron deficient women. Malar J. 2011;10:47.
23. Pena-Rosas JP, Viteri FE. Effects and safety of preventive oral iron or iron+folic acid supplementation for women during pregnancy. Cochrane Database Syst Rev. 2009;4:CD004736.
24. Ziaei S, Norrozi M, Faghihzadeh S, Jafarbegloo E. A randomised placebo-controlled trial to determine the effect of iron supplementation on pregnancy outcome in pregnant women with haemoglobin ≥ 13.2 g/dl. BJOG. 2007;114(6):684-8.
25. Weinberg ED. Are iron supplements appropriate for iron replete pregnant women? Med Hypotheses. 2009;73(5):714-5.
26. Sangare L, van Eijk AM, Ter Kuile FO, Walson J, Stergachis A. The association between malaria and iron status or supplementation in pregnancy: a systematic review and meta-analysis. PLoS One. 2014;9(2):e87743.
27. Pena-Rosas JP, De-Regil LM, Dowswell T, Viteri FE. Daily oral iron supplementation during pregnancy. Cochrane Database Syst Rev. 2012;12:Cd004736.
28. Reveiz L, Gyte GM, Cuervo LG, Casasbuenas A. Treatments for iron-deficiency anaemia in pregnancy. Cochrane Database Syst Rev. 2011;10:CD003094.
29. WHO. Guideline: daily iron and folic acid supplementation in pregnant women. Geneva: World Health Organisation; 2012.
30. Bhutta ZA, Ahmed T, Black RE, Cousens S, Dewey K, Giugliani E, Haider BA, Kirkwood B, Morris SS, Sachdev HP and Shekar M. What works? Interventions for maternal and child undernutrition and survival. Lancet. 2008;371(9610):417-40.
31. Moore SE, Fulford AJ, Darboe MK, Jobarteh ML, Jarjou LM, Prentice AM. A randomized trial to investigate the effects of pre-natal and infant nutritional supplementation on infant immune development in rural Gambia: the ENID trial: Early Nutrition and Immune Development. BMC Pregnancy Childbirth. 2012;12(1):107.
32. Clark MA, Goheen MM, Spidale NA, Kasthuri RS, Fulford A, Cerami C. RBC barcoding allows for the study of erythrocyte population dynamics and P. falciparum merozoite invasion. PLoS One. 2014;9(7):e101041.
33. Cross JH, Bradbury RS, Fulford AJ, Jallow AT, Wegmüller R, Prentice A M, Cerami C. Oral iron acutely elevates bacterial growth in human serum. Scientific Reports, 5, 16670. 2015. http://doi.org/10.1038/srep16670.
34. Fall CH, Fisher DJ, Osmond C, Margetts BM. Multiple micronutrient supplementation during pregnancy in low-income countries: a meta-analysis of effects on birth size and length of gestation. Food Nutr Bull. 2009;30(4 Suppl):S533-46.